Transverse myelitis associated with autoimmune polyglandular syndrome type 3B: A case report in Peru
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Vences, Miguel A.Morocho-Pinedo, Milene
Oliveros-Ramirez, Rossy J.
Ballena-Cupe, Lizset C.
Alvarez-Márquez, Julio C.
Villafuerte-Espinoza, Mirla
Urrunaga-Pastor, Diego
Issue Date
2023-01-01Keywords
Autoimmune diseasesAutoimmune polyendocrine syndromes
Multiple autoimmune syndromes
Peru
Polyendocrinopathies
Transverse myelitis
Parietal Antibody-Positive Gastritis
Central Retinal Vein Obstruction
Transverse Myelitis
Euthyroid Autoimmune Thyroid Disease
Methylprednisolone
Immunoglobulin
Cyclophosphamide
Azathioprine
Paraparesis
Metadata
Show full item recordPublisher
Ediciones Doyma, S.L.Journal
Neurologia ArgentinaDOI
https://doi.org/10.1016/j.neuarg.2023.01.001Additional Links
https://www.elsevier.es/es-revista-neurologia-argentina-301-avance-resumen-transverse-myelitis-associated-with-autoimmune-S1853002823000058Abstract
Autoimmune polyglandular syndrome is a rare disease with a low incidence worldwide. We present the case of an adult male with a history of parietal antibody-positive gastritis, central retinal vein obstruction and transverse myelitis. The patient was admitted for exacerbation of myelitis symptoms. The thyroid profile was positive for antibodies, indicating the presence of euthyroid autoimmune thyroid disease. The patient was finally diagnosed with autoimmune polyglandular syndrome type 3B. In the absence of adequate response to methylprednisolone and immunoglobulin, we started treatment with cyclophosphamide and later maintenance therapy with azathioprine. At one year of follow-up, the patient presented paraparesis as sequel, did not present new relapses and control tests were negative for another associated disease.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/embargoedAccessLanguage
engISSN
18530028Sponsors
Universidad Científica del Surae974a485f413a2113503eed53cd6c53
https://doi.org/10.1016/j.neuarg.2023.01.001
Scopus Count
Collections
Related items
Showing items related by title, author, creator and subject.
-
Vitamin B12 levels in thyroid disorders: A systematic review and meta-analysisBenites-Zapata, Vicente A.; Ignacio-Cconchoy, Felipe L.; Ulloque-Badaracco, Juan R.; Hernandez-Bustamante, Enrique A.; Alarcón-Braga, Esteban A.; Al-kassab-Córdova, Ali; Herrera-Añazco, Percy (Frontiers Media S.A., 2023-01-01)Background and aims: Numerous studies have found an association between vitamin deficiency and thyroid disorders (TD). The presence of anti-parietal cell antibodies is indicative of reduced ability to absorb vitamin B12. Thus, this study reviewed the existing studies with the objective of assessing differences in the serum levels of vitamin B12 among patients with and without TD, the frequency of vitamin B12 deficiency in patients with TD, and the presence of anti-parietal cell antibodies in patients with TD. Methods: A meta-analysis of random-effects model was conducted to calculate pooled frequencies, mean differences (MD), and their respective 95% confidence intervals (CI). We identified 64 studies that met our inclusion criteria (n = 28597). Results: We found that patients with hypothyroidism had lower vitamin B12 levels than healthy participants (MD: −60.67 pg/mL; 95% CI: −107.31 to −14.03 pg/mL; p = 0.01). No significant differences in vitamin B12 levels were observed between healthy participants and patients with hyperthyroidism (p = 0.78), autoimmune thyroid disease (AITD) (p = 0.22), or subclinical hypothyroidism (SH) (p = 0.79). The frequencies of vitamin B12 deficiency among patients with hypothyroidism, hyperthyroidism, SH, and AITD were 27%, 6%, 27%, and 18%, respectively. Conclusions: Patients with hypothyroidism had lower levels of vitamin B12 than healthy participants. No significant differences were observed between vitamin B12 levels and hyperthyroidism, AITD, or SH. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=324422, identifier (CRD42022324422). Copyright © 2023 Benites-Zapata, Ignacio-Cconchoy, Ulloque-Badaracco, Hernandez-Bustamante, Alarcón-Braga, Al-kassab-Córdova and Herrera-Añazco.Acceso abierto -
Síntomas clínicos asociados a la presencia de patrón moteado fino denso en adultos con anticuerpos antinucleares positivo y con sospecha de enfermedad reumática autoinmune sistémica atendidos en el consultorio de Reumatología del Hospital Nacional Edgardo Rebagliati Martins durante el 2020-2022PRIALE PRIALE, GRACIELA CELINA; Mayhuasca Crespo, Cristina Isabel; Ramos Sanchez, Ariana Valeria (Universidad Peruana de Ciencias Aplicadas (UPC)PE, 2025-11-12)Objetivos: Evaluar los síntomas clínicos asociados a la presencia del patrón moteado fino denso (PMFD) en adultos con anticuerpos antinucleares (ANA) positivos y con sospecha de enfermedad reumática autoinmune sistémica (ERAS) atendidos en el consultorio de Reumatología del HNERM durante el 2020-2022.Métodos: Se realizó un estudio analítico, observacional, de corte transversal retrospectivo. La población estuvo conformada por pacientes adultos con ANA positivo y sospecha de ERAS atendidos en el consultorio de Reumatología del HNERM entre 2020 y 2022. Se incluyeron pacientes con primer resultado de ANA positivo y con historia clínica electrónica completa. Se excluyeron aquellos que no fueron atendidos en el consultorio y los que presentaron diagnóstico final de artritis reumatoide (AR).Resultados: Se identificaron 324 pacientes con primer resultado de ANA positivo, de los cuales 246 cumplieron los criterios de inclusión. Entre ellos, 25 presentaron PMFD y 221 no lo presentaron. El síntoma más frecuente fue dolor y rigidez articular; los pacientes que lo presentaron tuvieron 2,22 veces mayor probabilidad de desarrollar PMFD en comparación con quienes no lo presentaron (p < 0,05). Asimismo, los que manifestaron ≥ 2 síntomas mostraron 50% menos probabilidad de presentar PMFD frente a los que tuvieron ≤ 1 síntoma. En el análisis ajustado, los pacientes con diagnóstico confirmado de ERAS tuvieron 60% menos probabilidad de presentar PMFD en comparación con los que no lo tenían (p < 0,05).Conclusión: No se encontró asociación entre la cantidad de síntomas o un síntoma específico y la presencia del PMFD. Sin embargo, se observó que los pacientes adultos con ANA positivo y diagnóstico confirmado de ERAS presentaron menor probabilidad de desarrollar PMFD en comparación con aquellos sin diagnóstico final de ERAS.Acceso abierto
-
CASE REPORT: LIVER FAILURE AS A DEBUT OF AUTOIMMUNE HEPATITIS TRIGGERED BY DENGUE VIRUS IN A PREGNANT WOMANSato-Espinoza, Karina; Berrospi, Diego; Diaz-Ferrer, Javier (nstituto Nacional de Salud, 2024-04-01)Autoimmune hepatitis (AIH) is a complex condition with unclear origins, involving genetic susceptibility and environmental triggers that lead to immune system dysfunction. We report a case of a pregnant woman from a mosquito-borne disease-endemic area who presented jaundice, abdominal pain, and pruritus, complicated by acute liver failure. Immunological markers showed AIH triggered by dengue virus infection, which was confirmed by a positive IgM test. Treatment with supportive care followed by steroids and azathioprine resulted in favorable outcomes, averting the need for a liver transplant. Although AIH can be triggered by viruses, the role of dengue in its pathogenesis remains poorly understood. Regular clinical monitoring is vital for managing AIH, particularly during pregnancy, due to variable immune status and treatment responses. Further research is necessary to understand the link between dengue infection and AIH. Individualized treatment strategies are crucial, especially during pregnancy, in order to ensure favorable outcomes.Acceso abierto
